Skip to content

Incyte Corp

American pharmaceutical company

INCY Nasdaq SEC CIK 879169

Follow Incyte Weekly email: filings, results, news

News

9 stories filed under Incyte

Markets

Thread · 4 stories

How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

Markets 1 d ago

Incyte: Solid Strategies For Continued Growth, But A Possible Pullback Looms

Markets 16 d ago

Incyte Corporation: Why Jakafi Is No Longer The Real Story Here

Markets 22 d ago

BMO reiterates Incyte stock rating on CMS pricing agreement

Markets 23 d ago also on BMO CMS

More coverage

Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?

Markets 26 d ago also on RVMD

Incyte stock price target maintained at $150 by H.C. Wainwright

Markets 28 d ago

Incyte Stock: Is Wall Street Bullish or Bearish?

Markets 37 d ago

Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?

Markets 41 d ago also on HALO

Incyte Sales Growth Drives Share Price Gains

Markets 43 d ago

Next results

OCT27

Q1 2026 results

Tuesday · estimated from the filing cadence

Profile

Headquarters: WILMINGTON, DE, United States
Founded: 2001
Sector: Healthcare
Industry: Services-Commercial Physical & Biological Research
Website: incyte.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 9 stories clustered from the RSS aggregator